Literature DB >> 17109292

Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.

Gregory A Lamaris1, Georgios Chamilos, Russell E Lewis, Amar Safdar, Issam I Raad, Dimitrios P Kontoyiannis.   

Abstract

We reviewed the records of patients with cancer who had Scedosporium infection (due to Scedosporium apiospermum and Scedosporium prolificans in 21 and 4 patients, respectively). The incidence of Scedosporium infection increased from 0.82 cases per 100,000 patient-inpatient days (in 1993-1998) to 1.33 cases per 100,000 patient-inpatient days (in 1999-2005). Cases of S. prolificans infection occurred only after 2000. Dissemination occurred in 16 patients (64%). The 12-week mortality rates were 70% and 100% for S. apiospermum and S. prolificans infection, respectively.

Entities:  

Mesh:

Year:  2006        PMID: 17109292     DOI: 10.1086/509579

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

Review 1.  Mucormycosis, pseudallescheriasis, and other uncommon mold infections.

Authors:  Clifford Quan; Brad Spellberg
Journal:  Proc Am Thorac Soc       Date:  2010-05

Review 2.  Invasive fungal infections in transplant recipients.

Authors:  Jose A Vazquez; Marisa H Miceli; George Alangaden
Journal:  Ther Adv Infect Dis       Date:  2013-06

3.  Synthesis and antifungal activity of functionalized 2,3-spirostane isomers.

Authors:  Sunil Kumar Upadhyay; Clinton C Creech; Katharine L Bowdy; Edwin D Stevens; Branko S Jursic; Donna M Neumann
Journal:  Bioorg Med Chem Lett       Date:  2011-03-30       Impact factor: 2.823

4.  Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.

Authors:  Frédéric Lamoth; Barbara D Alexander
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

5.  Granulocyte macrophage colony-stimulating factor in 66 patients with myeloid or lymphoid neoplasms and recipients of hematopoietic stem cell transplantation with invasive fungal disease.

Authors:  Amar Safdar; Gilhen Rodriguez; Jorge Zuniga; Fadi Al Akhrass; Georgia Georgescu; Anupam Pande
Journal:  Acta Haematol       Date:  2012-10-02       Impact factor: 2.195

6.  Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma.

Authors:  Natasha E Holmes; Janine M Trevillyan; Sarah E Kidd; Trishe Y-M Leong
Journal:  Med Mycol Case Rep       Date:  2013-04-19

Review 7.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 8.  Host immune response against Scedosporium species.

Authors:  Emmanuel Roilides; Maria Simitsopoulou; Aspasia Katragkou; Thomas J Walsh
Journal:  Med Mycol       Date:  2009-01-31       Impact factor: 4.076

9.  Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations.

Authors:  D Lin; Q Kamili; K Qurat-Ul-Ain; S Lai; D M Musher; R Hamill
Journal:  Infection       Date:  2013-02-26       Impact factor: 3.553

10.  Infection with Scedosporium apiospermum and S. prolificans, Australia.

Authors:  Louise Cooley; Denis Spelman; Karin Thursky; Monica Slavin
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.